Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

3.910

+0.050 (1.30%)

At close: May 16, 2025, 4:00 PM

3.910

0.00 (0.00%)

After-hours: May 16, 2025, 6:50 PM EDT

Avalo Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	0.44	0.44	1.92	18.05	5.4	6.7	Upgrade
Revenue Growth (YoY)	-69.56%	-77.08%	-89.34%	234.40%	-19.42%	-0.76%	Upgrade
Cost of Revenue	15.36	15.28	9.95	25.99	50.12	25.24	Upgrade
Gross Profit	-14.92	-14.84	-8.02	-7.94	-44.72	-18.54	Upgrade
Selling, General & Admin	19.59	17.24	10.3	13.91	24.66	19.76	Upgrade
Research & Development	15.8	8.8	5.12	8.05	11.21	7.26	Upgrade
Operating Expenses	35.4	26.04	15.42	22	37.41	28.76	Upgrade
Operating Income	-50.31	-40.87	-23.44	-29.94	-82.13	-47.29	Upgrade
Interest Expense	-	-	-3.42	-4.17	-2.39	-	Upgrade
Interest & Investment Income	4.37	3.32	-	-	-	0.05	Upgrade
Other Non Operating Income (Expenses)	119.18	30.18	-0.76	-0.02	-0.02	0.41	Upgrade
EBT Excluding Unusual Items	73.23	-7.37	-27.62	-34.13	-84.55	-46.84	Upgrade
Merger & Restructuring Charges	-	-	-	-7.5	-	-	Upgrade
Impairment of Goodwill	-	-	-3.91	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	-	5.21	Upgrade
Pretax Income	73.13	-35.02	-31.53	-41.63	-84.55	-67.18	Upgrade
Income Tax Expense	0.12	0.11	0.01	0.03	-0.2	-2.79	Upgrade
Earnings From Continuing Operations	73.01	-35.13	-31.54	-41.66	-84.35	-64.38	Upgrade
Earnings From Discontinued Operations	-	-	-	-	-0.03	0.88	Upgrade
Net Income	73.01	-35.13	-31.54	-41.66	-84.38	-63.5	Upgrade
Net Income to Common	73.01	-35.13	-31.54	-41.66	-84.38	-63.5	Upgrade
Shares Outstanding (Basic)	7	4	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	10	7	0	0	0	0	Upgrade
Shares Change (YoY)	1963.31%	2599.19%	608.45%	8.32%	41.86%	28.52%	Upgrade
EPS (Basic)	10.67	-7.94	-113.58	-1062.65	-2331.41	-2489.12	Upgrade
EPS (Diluted)	-4.90	-20.91	-113.58	-1062.65	-2331.41	-2489.12	Upgrade
Free Cash Flow	-52.31	-49.06	-30.84	-26.85	-71.01	-40.6	Upgrade
Free Cash Flow Per Share	-5.28	-6.54	-111.04	-684.81	-1961.95	-1591.55	Upgrade
Gross Margin	-	-	-	-43.98%	-	-276.70%	Upgrade
Operating Margin	-11408.39%	-9267.80%	-1218.50%	-165.86%	-1521.56%	-705.99%	Upgrade
Profit Margin	16556.01%	-7965.76%	-1639.50%	-230.78%	-1563.10%	-947.90%	Upgrade
Free Cash Flow Margin	-11861.91%	-11123.81%	-1602.81%	-148.72%	-1315.39%	-606.09%	Upgrade
EBITDA	-50.04	-40.7	-23.29	-29.77	-80.48	-45.45	Upgrade
EBITDA Margin	-	-	-	-164.94%	-	-	Upgrade
D&A For EBITDA	0.27	0.17	0.16	0.17	1.66	1.84	Upgrade
EBIT	-50.31	-40.87	-23.44	-29.94	-82.13	-47.29	Upgrade
EBIT Margin	-	-	-	-165.86%	-	-	Upgrade
Effective Tax Rate	0.16%	-	-	-	-	-	Upgrade
Revenue as Reported	0.44	0.44	1.92	18.05	5.4	6.7	Upgrade

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q